BioSpace News Archive

Quest Diagnostics Incorporated announced that its 2020 Annual Meeting of Stockholders will now be held solely by remote communication through a live, online audio webcast.

Invitae Corporation, a leading medical genetics company, announced financial and operating results for the first quarter ended March 31, 2020.

Jazz Pharmaceuticals plc announced financial results for the first quarter of 2020 and updated 2020 financial guidance.

Axcella, a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators to pioneer a new approach for treating complex diseases and improving health, announced that it plans to report top-line data from AXA1125-003 on May 6, 2020 and will host a conference call at 8:30 a.m. ET that morning.

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation devices for the treatment of urinary and bowel dysfunction, reported financial results for the first quarter 2020 and provided an update on operational initiatives.

NDA for Ripretinib for the Treatment of Advanced GIST Under Review by U.S. FDA with PDUFA Date of August 13, 2020; Commercial Preparations Underway to Support Potential Launch

Cerus Corporation announced financial results for the first quarter ended March 31, 2020.

ACADIA Pharmaceuticals Inc. announced that it will present at the following two investor conferences

Dosing of patients with locally advanced or metastatic solid tumors has commenced in the DRAGON Phase 1 clinical trial of SRK-181, a highly specific inhibitor of latent TGFβ1 activation

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, reported financial results for the quarter ended March 31, 2020, and provided a corporate update.